Taysha Gene Therapies
TSHA
#7372
Rank
S$0.40 B
Marketcap
$1.99
Share price
5.63%
Change (1 day)
-3.12%
Change (1 year)

Taysha Gene Therapies (TSHA) - Cash on Hand

Cash on Hand as of June 2024 : S$0.22 Billion

According to Taysha Gene Therapies's latest financial reports the company has S$0.22 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Taysha Gene Therapies - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$0.11 B-41.55%
2021-12-31S$0.20 B-39.36%
2020-12-31S$0.33 B
2019-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.38 B 65.80%๐Ÿ‡บ๐Ÿ‡ธ USA